Biologics
Biologics
Advance your biologics pipeline with comprehensive protein characterization, potency assays, immunogenicity assessment, and bioanalytical detection platforms.
Tools for the Biologics Pipeline
Biologics development requires specialized analytical tools to characterize complex protein therapeutics throughout the development lifecycle. Enzo Life Sciences provides a broad portfolio of reagents and assay platforms for biologics characterization — from protein quantification and purity analysis to functional potency assays and immunogenicity testing — supporting development from early candidate selection through process validation.
Protein Characterization
Quantitative protein assays, electrophoresis reagents, and binding assays for physicochemical characterization of biologic drug substances. Support structural integrity, aggregation, and post-translational modification analysis of antibodies, fusion proteins, and cytokines.
Potency & Bioactivity
Functional cell-based potency assays and biochemical activity measurements for biologics lot release and stability testing. Validated platforms for measuring cytokine bioactivity, receptor binding, and downstream signaling in compliance-ready formats.
Immunogenicity Assessment
Anti-drug antibody (ADA) detection kits, cytokine release assays, and immune activation panels for assessing biologic immunogenicity. Bridging ELISA formats and multiplex platforms for comprehensive immunogenicity risk evaluation.
Bioanalytical Detection
Sensitive ELISA and multiplex immunoassay platforms for pharmacokinetic and biomarker quantification in biological matrices. Validated for serum, plasma, and tissue samples with the sensitivity required for PK/PD modeling of biologics.
Biologics — By the Numbers
Advance Your Biologics Program
Explore our curated product selection or contact our scientific support team for personalized recommendations.